This study constructs new engineered exosomes that can efficiently deliver therapeutic contents to pro‐inflammatory macrophages mainly through TLR4‐mediated endocytosis, thereby ameliorating the severity of arthritis in vivo. Here, TLR4 is linked to Arthritis.